Jump to content

COVID-19 vaccine: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Line 38: Line 38:
==Rumors and misinformation==
==Rumors and misinformation==
{{main article|Misinformation related to the 2019–20 coronavirus pandemic}}
{{main article|Misinformation related to the 2019–20 coronavirus pandemic}}
Social media posts have promoted a [[conspiracy theory]] claiming the virus behind COVID-19 was known and that a vaccine was already available, while in fact there is none. The patents cited by various [[social media]] posts reference existing patents for [[genetic sequence]]s and vaccines for other strains of coronavirus such as the [[Severe acute respiratory syndrome-related coronavirus|SARS coronavirus]].<ref>{{Cite web|url=https://www.politifact.com/factchecks/2020/jan/23/facebook-posts/there-outbreak-china-wuhan-coronavirus-there-not-v/|title=No, there is no vaccine for the Wuhan coronavirus|last=Kertscher|first=Tom|date=23 January 2020|website=[[PolitiFact]]|publisher=[[Poynter Institute]]|url-status=live|archive-url=https://web.archive.org/web/20200207133056/https://www.politifact.com/factchecks/2020/jan/23/facebook-posts/there-outbreak-china-wuhan-coronavirus-there-not-v/|archive-date=7 February 2020|access-date=7 February 2020}}</ref><ref name="20200124factcheckA">{{Cite web|url=https://www.factcheck.org/2020/01/social-media-posts-spread-bogus-coronavirus-conspiracy-theory/|title=Social Media Posts Spread Bogus Coronavirus Conspiracy Theory|last=McDonald|first=Jessica|date=24 January 2020|website=[[FactCheck.org]]|publisher=[[Annenberg Public Policy Center]]|url-status=live|archive-url=https://web.archive.org/web/20200206102802/https://www.factcheck.org/2020/01/social-media-posts-spread-bogus-coronavirus-conspiracy-theory/|archive-date=6 February 2020|access-date=8 February 2020}}</ref>
Social media posts have promoted a [[conspiracy theory]] claiming the virus behind COVID-19 was known and that a vaccine was already available. The patents cited by various [[social media]] posts reference existing patents for [[genetic sequence]]s and vaccines for other strains of coronavirus such as the [[Severe acute respiratory syndrome-related coronavirus|SARS coronavirus]].<ref>{{Cite web|url=https://www.politifact.com/factchecks/2020/jan/23/facebook-posts/there-outbreak-china-wuhan-coronavirus-there-not-v/|title=No, there is no vaccine for the Wuhan coronavirus|last=Kertscher|first=Tom|date=23 January 2020|website=[[PolitiFact]]|publisher=[[Poynter Institute]]|url-status=live|archive-url=https://web.archive.org/web/20200207133056/https://www.politifact.com/factchecks/2020/jan/23/facebook-posts/there-outbreak-china-wuhan-coronavirus-there-not-v/|archive-date=7 February 2020|access-date=7 February 2020}}</ref><ref name="20200124factcheckA">{{Cite web|url=https://www.factcheck.org/2020/01/social-media-posts-spread-bogus-coronavirus-conspiracy-theory/|title=Social Media Posts Spread Bogus Coronavirus Conspiracy Theory|last=McDonald|first=Jessica|date=24 January 2020|website=[[FactCheck.org]]|publisher=[[Annenberg Public Policy Center]]|url-status=live|archive-url=https://web.archive.org/web/20200206102802/https://www.factcheck.org/2020/01/social-media-posts-spread-bogus-coronavirus-conspiracy-theory/|archive-date=6 February 2020|access-date=8 February 2020}}</ref>


==See also==
==See also==

Revision as of 10:03, 21 March 2020

A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine. In late February 2020, the World Health Organization (WHO) said it did not expect a vaccine against SARS-CoV-2, the causative virus, to become available in less than 18 months.[1] By early March 2020, some 30 vaccine candidates were in development.

Previous coronavirus vaccine efforts

Vaccines have been produced against several diseases caused by coronaviruses for animal use, including for infectious bronchitis virus in birds, canine coronavirus and feline coronavirus.[2]

Previous efforts to develop vaccines for viruses in the family Coronaviridae that affect humans have been aimed at severe acute respiratory syndrome coronavirus (SARS) and Middle East respiratory syndrome (MERS). Vaccines against SARS[3] and MERS[4] have been tested in non-human animal models. As of 2020, there is no cure or protective vaccine for SARS that has been shown to be both safe and effective in humans.[5][6] According to research papers published in 2005 and 2006, the identification and development of novel vaccines and medicines to treat SARS is a priority for governments and public health agencies around the world.[7][8][9]

There is also no proven vaccine against MERS.[10] When MERS became prevalent, it was believed that existing SARS research may provide a useful template for developing vaccines and therapeutics against a MERS-CoV infection.[5][11] As of March 2020, there was one (DNA based) MERS vaccine which completed phase I clinical trials in humans,[12] and three others in progress, all of which are viral vectored vaccines, two adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac), and one MVA-vectored (MVA-MERS-S).[13]

2020 efforts

SARS-CoV-2 was identified in late 2019 as the cause of what would later be named COVID-19.[14] A major outbreak spread around the world in 2020, leading to considerable investment and research activity to develop a vaccine.[14][15] Many organizations are using published genomes to develop possible vaccines against SARS-CoV-2.[14][16][17][18] About 35 companies and academic institutions are involved,[19] with three of them receiving support from the Coalition for Epidemic Preparedness Innovations (CEPI), including projects by the biotechnology companies Moderna,[20] and Inovio Pharmaceuticals, and the University of Queensland.[21] Some 300 clinical studies are in progress, as of March 2020.[22]

The difficulty with vaccine development is that older people who are most vulnerable to infection are poorly vaccinated due to age-related degradation of the thymus. Therefore, along with the development of a vaccine, it is necessary to develop ways to increase immunity in these people. One of these methods can be treatment with recombinant interleukin 7. Interleukin 7 plays an extremely important role in the maturation and reproduction of lymphoid cells. Therefore, it makes sense, along with vaccines, to develop methods for restoring the immune function in the elderly, for example, by improving it using treatment with recombinant interleukin 7[23][24].


Clinical trials in progress

Preclinical research

Rumors and misinformation

Social media posts have promoted a conspiracy theory claiming the virus behind COVID-19 was known and that a vaccine was already available. The patents cited by various social media posts reference existing patents for genetic sequences and vaccines for other strains of coronavirus such as the SARS coronavirus.[46][47]

See also

References

  1. ^ Grenfell, Rob; Drew, Trevor (17 February 2020). "Here's Why It's Taking So Long to Develop a Vaccine for the New Coronavirus". ScienceAlert. Archived from the original on 28 February 2020. Retrieved 26 February 2020.
  2. ^ Cavanagh, Dave (2003). "Severe acute respiratory syndrome vaccine development: Experiences of vaccination against avian infectious bronchitis coronavirus". Avian Pathology. 32 (6): 567–582. doi:10.1080/03079450310001621198. PMID 14676007.
  3. ^ Gao, Wentao; Tamin, Azaibi; Soloff, Adam; d'Aiuto, Leonardo; Nwanegbo, Edward; Robbins, Paul D.; Bellini, William J.; Barratt-Boyes, Simon; Gambotto, Andrea (2003). "Effects of a SARS-associated coronavirus vaccine in monkeys". The Lancet. 362 (9399): 1895–1896. doi:10.1016/S0140-6736(03)14962-8. PMID 14667748.
  4. ^ Kim, Eun; Okada, Kaori; Kenniston, Tom; Raj, V. Stalin; Alhajri, Mohd M.; Farag, Elmoubasher A.B.A.; Alhajri, Farhoud; Osterhaus, Albert D.M.E.; Haagmans, Bart L.; Gambotto, Andrea (2014). "Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/C mice". Vaccine. 32 (45): 5975–5982. doi:10.1016/j.vaccine.2014.08.058. PMID 25192975.
  5. ^ a b Jiang, Shibo; Lu, Lu; Du, Lanying (2013). "Development of SARS vaccines and therapeutics is still needed". Future Virology. 8 (1): 1–2. doi:10.2217/fvl.12.126.
  6. ^ "SARS (severe acute respiratory syndrome)". National Health Service. 5 March 2020. Archived from the original on 9 March 2020. Retrieved 31 January 2020.
  7. ^ Greenough, Thomas C.; Babcock, Gregory J.; Roberts, Anjeanette; Hernandez, Hector J.; Thomas, Jr., William D.; Coccia, Jennifer A.; Graziano, Robert F.; Srinivasan, Mohan; Lowy, Israel; Finberg, Robert W.; Subbarao, Kanta; Vogel, Leatrice; Somasundaran, Mohan; Luzuriaga, Katherine; Sullivan, John L.; Ambrosino, Donna M. (15 February 2005). "Development and Characterization of a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice". The Journal of Infectious Diseases. 191 (4): 507–14. doi:10.1086/427242. PMID 15655773. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  8. ^ Tripp, Ralph A.; Haynes, Lia M.; Moore, Deborah; Anderson, Barbara; Tamin, Azaibi; Harcourt, Brian H.; Jones, Les P.; Yilla, Mamadi; Babcock, Gregory J.; Greenough, Thomas; Ambrosino, Donna M.; Alvarez, Rene; Callaway, Justin; Cavitt, Sheana; Kamrud, Kurt; Alterson, Harold; Smith, Jonathan; Harcourt, Jennifer L.; Miao, Congrong; Razdan, Raj; Comer, James A.; Rollin, Pierre E.; Ksiazek, Thomas G.; Sanchez, Anthony; Rota, Paul A.; Bellini, William J.; Anderson, Larry J. (September 2005). "Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins". Journal of Virological Methods. 128 (1–2): 21–8. doi:10.1016/j.jviromet.2005.03.021. PMID 15885812. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  9. ^ Roberts, Anjeanette; Thomas, William D.; Guarner, Jeannette; Lamirande, Elaine W.; Babcock, Gregory J.; Greenough, Thomas C.; Vogel, Leatrice; Hayes, Norman; Sullivan, John L.; Zaki, Sherif; Subbarao, Kanta; Ambrosino, Donna M. (March 2006). "Therapy with a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian Hamsters". The Journal of Infectious Diseases. 193 (5): 685–92. doi:10.1086/500143. PMID 16453264. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  10. ^ Shehata, M.M., Gomaa, M.R., Ali, M.A. et al. Middle East respiratory syndrome coronavirus: a comprehensive review. Front. Med. 10, 120–136 (2016). doi:10.1007/s11684-016-0430-6
  11. ^ Butler, Declan (October 2012). "SARS veterans tackle coronavirus". Nature. 490 (7418): 20. Bibcode:2012Natur.490...20B. doi:10.1038/490020a. PMID 23038444.
  12. ^ Modjarrad, Kayvon; Roberts, Christine C.; Mills, Kristin T.; Castellano, Amy R.; Paolino, Kristopher; Muthumani, Kar; Reuschel, Emma L.; Robb, Merlin L.; Racine, Trina; Oh, Myoung-don; Lamarre, Claude; Zaidi, Faraz I.; Boyer, Jean; Kudchodkar, Sagar B.; Jeong, Moonsup; Darden, Janice M.; Park, Young K.; Scott, Paul T.; Remigio, Celine; Parikh, Ajay P.; Wise, Megan C.; Patel, Ami; Duperret, Elizabeth K.; Kim, Kevin Y.; Choi, Hyeree; White, Scott; Bagarazzi, Mark; May, Jeanine M.; Kane, Deborah; Lee, Hyojin (2019). "Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial". The Lancet Infectious Diseases. 19 (9): 1013–1022. doi:10.1016/S1473-3099(19)30266-X. PMID 31351922. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  13. ^ Yong, Chean Yeah; Ong, Hui Kian; Yeap, Swee Keong; Ho, Kok Lian; Tan, Wen Siang (2019). "Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus". Frontiers in Microbiology. 10: 1781. doi:10.3389/fmicb.2019.01781. PMC 6688523. PMID 31428074.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  14. ^ a b c Fauci, Anthony S.; Lane, H. Clifford; Redfield, Robert R. (28 February 2020). "Covid-19 — Navigating the Uncharted". New England Journal of Medicine. doi:10.1056/nejme2002387. ISSN 0028-4793.
  15. ^ Gates, Bill (28 February 2020). "Responding to Covid-19 — A Once-in-a-Century Pandemic?". New England Journal of Medicine. doi:10.1056/nejmp2003762. ISSN 0028-4793.
  16. ^ a b Steenhuysen, Julie; Kelland, Kate (24 January 2020). "With Wuhan virus genetic code in hand, scientists begin work on a vaccine". Reuters. Archived from the original on 25 January 2020. Retrieved 25 January 2020. {{cite news}}: Unknown parameter |name-list-format= ignored (|name-list-style= suggested) (help)
  17. ^ Praveen Duddu. Coronavirus outbreak: Vaccines/drugs in the pipeline for Covid-19 Archived 19 February 2020 at the Wayback Machine. clinicaltrialsarena.com 19 February 2020.
  18. ^ Lee, Jaimy (7 March 2020). "These nine companies are working on coronavirus treatments or vaccines — here's where things stand". MarketWatch. Retrieved 7 March 2020.{{cite news}}: CS1 maint: url-status (link)
  19. ^ Laura Spinney (18 March 2020). "When will a coronavirus vaccine be ready?". The Guardian. Retrieved 18 March 2020.
  20. ^ a b Ziady, Hanna (26 February 2020). "Biotech company Moderna says its coronavirus vaccine is ready for first tests". CNN. Archived from the original on 28 February 2020. Retrieved 2 March 2020.
  21. ^ a b Devlin, Hannah (24 January 2020). "Lessons from SARS outbreak help in race for coronavirus vaccine". The Guardian. Archived from the original on 25 January 2020. Retrieved 25 January 2020.
  22. ^ Hannah Devlin; Ian Sample (10 March 2020). "Hopes rise over experimental drug's effectiveness against coronavirus". The Guardian. Retrieved 19 March 2020.
  23. ^ Aspinall, R., & Lang, P. O. (2018). Interventions to restore appropriate immune function in the elderly. Immunity & Ageing, 15(1), 5. doi:10.1186/s12979-017-0111-6 PMC 5785902
  24. ^ Aspinall, R., & Lang, P. O. (2018). Interleukin-7 and Immunorejuvenation In: Fulop T., Franceschi C., Hirokawa K., Pawelec G. (eds) Handbook of Immunosenescence. Springer, Cham. https://doi.org/10.1007/978-3-319-64597-1_72-1
  25. ^ a b "NIH clinical trial of investigational vaccine for COVID-19 begins". US National Institutes of Health. 16 March 2020. Retrieved 17 March 2020.
  26. ^ "Saskatchewan lab joins global effort to develop coronavirus vaccine". CBC News. The Canadian Press. 24 January 2020. Archived from the original on 25 January 2020. Retrieved 25 January 2020.
  27. ^ Vescera, Zak (6 March 2020). "U of S team gets federal dollars to develop COVID-19 vaccine". Saskatoon StarPhoenix. Archived from the original on 9 March 2020. Retrieved 7 March 2020.
  28. ^ Jeong-ho, Lee; Zheng, William; Zhou, Laura (26 January 2020). "Chinese scientists race to develop vaccine as coronavirus death toll jumps". South China Morning Post. Archived from the original on 26 January 2020. Retrieved 28 January 2020.
  29. ^ Cheung, Elizabeth (28 January 2020). "Hong Kong researchers have developed coronavirus vaccine, expert reveals". South China Morning Post. Archived from the original on 28 January 2020. Retrieved 28 January 2020.
  30. ^ Mishra, Manas (29 January 2020). Orr, Bernard; Kuber, Shailesh (eds.). "Johnson & Johnson working on vaccine for deadly coronavirus". Reuters. Archived from the original on 29 January 2020. Retrieved 19 February 2020.
  31. ^ "Vaxart (VXRT) - A long shot or perfect shot?". NASDAQ, RTTNews.com. 25 February 2020. Retrieved 1 March 2020.
  32. ^ Sara Gilgore (18 March 2020). "Emergent BioSolutions dives into another coronavirus vaccine effort". Washington Business Journal. Retrieved 18 March 2020.
  33. ^ Mazumdar, Tulip (30 January 2020). "Coronavirus: Scientists race to develop a vaccine". BBC News. Archived from the original on 30 January 2020. Retrieved 3 February 2020.
  34. ^ "Novel Coronavirus vaccine manufacturing contract signed".
  35. ^ "The vaccine hunters racing to save the world from the coronavirus pandemic". 14 March 2020. Retrieved 18 March 2020.
  36. ^ "Trials to begin on Covid-19 vaccine in UK next month".
  37. ^ Chen, Eli (5 March 2020). "Wash U Scientists Are Developing A Coronavirus Vaccine". news.stlpublicradio.org. Retrieved 19 March 2020.
  38. ^ "Defense Department Press Briefing Investigating and Developing Vaccine Candidates Against COVID-19 (Transcript)". Arlington, VA: United States Department of Defense. 5 March 2020. Retrieved 19 March 2020.
  39. ^ "KU-forskere får EU-bevilling til vaccine mod coronavirus" (in Danish). University of Copenhagen. 6 March 2020. Retrieved 19 March 2020.
  40. ^ Gilgore, Sara (10 March 2020). "Novavax's coronavirus vaccine program is getting some help from Emergent BioSolutions,". Washington Business Journal. Charlotte, NC: American City Business Journals.
  41. ^ Smith, Micholas; Smith, Jeremy C. (10 March 2020). "Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 Interface". ChemRXiv. doi:10.26434/chemrxiv.11871402.v4.
  42. ^ Andrew, Scottie (19 March 2020). "The world's fastest supercomputer identified chemicals that could stop coronavirus from spreading, a crucial step toward a vaccine". CNN. Retrieved 19 March 2020.
  43. ^ "Will take one-and-a-half to two years for India to develop vaccine for COVID-19: Health Ministry". Economic Times. 12 March 2020. Retrieved 12 March 2020.
  44. ^ "Coronavirus: Commission offers financing to innovative vaccines company CureVac". European Commission. 16 March 2020. Retrieved 19 March 2020.
  45. ^ "Pfizer and BioNTech announce joint development of a potential COVID-19 vaccine". TechCrunch. 18 March 2020. Retrieved 18 March 2020.
  46. ^ Kertscher, Tom (23 January 2020). "No, there is no vaccine for the Wuhan coronavirus". PolitiFact. Poynter Institute. Archived from the original on 7 February 2020. Retrieved 7 February 2020.
  47. ^ McDonald, Jessica (24 January 2020). "Social Media Posts Spread Bogus Coronavirus Conspiracy Theory". FactCheck.org. Annenberg Public Policy Center. Archived from the original on 6 February 2020. Retrieved 8 February 2020.